Ocriplasmin in the Treatment of Vitreomacular Traction in a Patient with Central Retinal Vein Occlusion: A Case Report

AIM: To investigate the efficacy of intravitreal injection of ocriplasmin (JETREA®) in the treatment of vitreomacular traction (VMT). MATERIALS AND METHODS: An 81-year-old man with VMT associated with central retinal vein occlusion in his left eye, was treated with a single intravitreal injection of...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosati, Alessandra, Esposito, Raffaele Antonio, Mannino, Giuseppe, Scuderi, Gianluca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6103348/
https://www.ncbi.nlm.nih.gov/pubmed/30140222
http://dx.doi.org/10.1159/000491487
_version_ 1783349333485158400
author Rosati, Alessandra
Esposito, Raffaele Antonio
Mannino, Giuseppe
Scuderi, Gianluca
author_facet Rosati, Alessandra
Esposito, Raffaele Antonio
Mannino, Giuseppe
Scuderi, Gianluca
author_sort Rosati, Alessandra
collection PubMed
description AIM: To investigate the efficacy of intravitreal injection of ocriplasmin (JETREA®) in the treatment of vitreomacular traction (VMT). MATERIALS AND METHODS: An 81-year-old man with VMT associated with central retinal vein occlusion in his left eye, was treated with a single intravitreal injection of ocriplasmin (25 μg). Best corrected visual acuity (BCVA), ocular fundus, and optical coherence tomography were examined before and after treatment. RESULTS: Complete release of VMT produced a reduction of central macular thickness, ranging from 459 to 141 μm. BCVA remained stable. DISCUSSION AND CONCLUSIONS: The use of ocriplasmin was effective in the treatment of VMT. Ocriplasmin represents a valid alternative to conventional pars plana vitrectomy.
format Online
Article
Text
id pubmed-6103348
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-61033482018-08-23 Ocriplasmin in the Treatment of Vitreomacular Traction in a Patient with Central Retinal Vein Occlusion: A Case Report Rosati, Alessandra Esposito, Raffaele Antonio Mannino, Giuseppe Scuderi, Gianluca Case Rep Ophthalmol Case Report AIM: To investigate the efficacy of intravitreal injection of ocriplasmin (JETREA®) in the treatment of vitreomacular traction (VMT). MATERIALS AND METHODS: An 81-year-old man with VMT associated with central retinal vein occlusion in his left eye, was treated with a single intravitreal injection of ocriplasmin (25 μg). Best corrected visual acuity (BCVA), ocular fundus, and optical coherence tomography were examined before and after treatment. RESULTS: Complete release of VMT produced a reduction of central macular thickness, ranging from 459 to 141 μm. BCVA remained stable. DISCUSSION AND CONCLUSIONS: The use of ocriplasmin was effective in the treatment of VMT. Ocriplasmin represents a valid alternative to conventional pars plana vitrectomy. S. Karger AG 2018-07-25 /pmc/articles/PMC6103348/ /pubmed/30140222 http://dx.doi.org/10.1159/000491487 Text en Copyright © 2018 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc/4.0/ This article is licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.
spellingShingle Case Report
Rosati, Alessandra
Esposito, Raffaele Antonio
Mannino, Giuseppe
Scuderi, Gianluca
Ocriplasmin in the Treatment of Vitreomacular Traction in a Patient with Central Retinal Vein Occlusion: A Case Report
title Ocriplasmin in the Treatment of Vitreomacular Traction in a Patient with Central Retinal Vein Occlusion: A Case Report
title_full Ocriplasmin in the Treatment of Vitreomacular Traction in a Patient with Central Retinal Vein Occlusion: A Case Report
title_fullStr Ocriplasmin in the Treatment of Vitreomacular Traction in a Patient with Central Retinal Vein Occlusion: A Case Report
title_full_unstemmed Ocriplasmin in the Treatment of Vitreomacular Traction in a Patient with Central Retinal Vein Occlusion: A Case Report
title_short Ocriplasmin in the Treatment of Vitreomacular Traction in a Patient with Central Retinal Vein Occlusion: A Case Report
title_sort ocriplasmin in the treatment of vitreomacular traction in a patient with central retinal vein occlusion: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6103348/
https://www.ncbi.nlm.nih.gov/pubmed/30140222
http://dx.doi.org/10.1159/000491487
work_keys_str_mv AT rosatialessandra ocriplasmininthetreatmentofvitreomaculartractioninapatientwithcentralretinalveinocclusionacasereport
AT espositoraffaeleantonio ocriplasmininthetreatmentofvitreomaculartractioninapatientwithcentralretinalveinocclusionacasereport
AT manninogiuseppe ocriplasmininthetreatmentofvitreomaculartractioninapatientwithcentralretinalveinocclusionacasereport
AT scuderigianluca ocriplasmininthetreatmentofvitreomaculartractioninapatientwithcentralretinalveinocclusionacasereport

Ejemplares similares